Skip to content
healthcare.dev

fulvestrant

NDC 25021-471, fulvestrant, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-471
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211422
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-471 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
25021-471-66250210471662 SYRINGE in 1 CARTON (25021-471-66) / 5 mL in 1 SYRINGE
25021-471-74250210471742 SYRINGE in 1 CARTON (25021-471-74) / 5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=25021-471
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-471

Use it

Look up 25021-471 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-471 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-471. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.